- Home
- HUM
HUM
Humana Inc.
as 10-29-2025 9:32am EST
Humana is one of the largest private health insurers in the US, and the firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from Medicare, Medicaid, and the military's Tricare program. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
| Founded: | 1961 | Country: | United States |
| Employees: | N/A | City: | LOUISVILLE |
| Market Cap: | 35.0B | IPO Year: | 1993 |
| Target Price: | $294.19 | AVG Volume (30 days): | 1.9M |
| Analyst Decision: | Buy | Number of Analysts: | 17 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 13.04 | EPS Growth: | -6.80 |
| 52 Week Low/High: | $206.87 - $315.35 | Next Earning Date: | 11-05-2025 |
| Revenue: | $123,110,000,000 | Revenue Growth: | 9.88% |
| Revenue Growth (this year): | 9.85% | Revenue Growth (next year): | 5.48% |
Latest Humana Inc. News
HUM Breaking Stock News: Dive into HUM Ticker-Specific Updates for Smart Investing
MT Newswires
23 days ago
Wolfe Research Adjusts Price Target on Humana to $313 From $283, Maintains Outperform Rating
Barchart
23 days ago
Stocks Set to Open Higher on Fed Rate-Cut Hopes and Earnings Optimism
StockStory
23 days ago
2 of Wall Street’s Favorite Stocks to Target This Week and 1 That Underwhelm
Investopedia
a month ago
S&P 500 Gains and Losses Today: Palantir Plunges; Health Insurance Stocks Surge
MT Newswires
a month ago
US Equity Markets Mixed After Hitting New Record Highs, Neutral Key Services Data
StockStory
a month ago
Why Is Humana (HUM) Stock Soaring Today
Zacks
a month ago
Humana (HUM) Moves 4.0% Higher: Will This Strength Last?
Barrons.com
a month ago
Health-Insurance Stocks Get a Lift From Early Release of Data on Humana
Compare HUM vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "HUM Humana Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.